No 10Y consistency score yet for revenue — the year-earlier revenue was zero, negative or too small a base to compare against in 15 of the 40 quarters in the window, leaving 25 comparable quarters; at least 28 are needed.
Valuation vs own 10Y history: P/S 714.8x · 10Y median 264.9x · 63rd percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T16:25:35.860Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Ainos, Inc. (AIMD) stock was $1.32 as of Oct 6, 2026, 12:13 PM EDT, down 0.75% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -62.1% · 3-year avg -55.7%/yr · 5-year avg -58.5%/yr
Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications.
Biotechnology · Houston, TX
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-0.62
vs Estimate
N/A
Revenue
$152.00
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AIMD | $9.72M | $1.32 | -0.75% | -62.15% | -58.50% | N/A | N/A |
| 2NMTC | $9.75M | $1.12 | +0.45% | -79.77% | -46.02% | N/A | vs AIMD |
| 3MTVA | $9.65M | $1.47 | -4.87% | -86.28% | N/A | N/A | vs AIMD |
| 4LFWD | $9.92M | $6.16 | -7.72% | -28.40% | -43.18% | -53.24% | vs AIMD |
| 5MDCX | $10.04M | $0.16 | -4.85% | -93.34% | N/A | N/A | vs AIMD |
| 6ICU | $9.37M | $3.30 | -7.04% | -45.14% | N/A | N/A | vs AIMD |
N/A
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$1.32
High
N/A
